speb/financial-data huggingface dataset:
Financial ratios for 8093.T — annual report dated 2025-03-31
Total revenue: 354110413.04638416
Gross profit: 73058414.6504478
Operating income: 13647908.033685336
Net income: 24856302.63333779
Capital expenditures: 0
Operating cash flow: -5333511.562625317
Depreciation & amortization: 2472931.426279909
Net tangible assets: 193242881.96765137
Owner earnings: 27329234.0596177
Return on net tangible assets (%): 14.142427281845539
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.057478946664883
P/E ratio: 4.829383894380209
Shares outstanding: 11935459
Book value: 196197032.48228842
P/B ratio: 0.6118371215533981
Market cap (USD): 120040627.6112819
Debt to equity: 0.2604326349855221
Current ratio: 1.76154187331156
Quick ratio: 1.4601427361799928
Effective tax rate (%): 18.777292576419214
Interest coverage ratio: 30.93939393939394
COGS to revenue (%): 79.36657732814919
Free cash flow (dilution-adjusted): -5333511.562625317
Buyback yield (%): 1.1024205048873366
Retained earnings: 71915519.31559952
Inventory turnover: 5.625418060200669
Receivables turnover: 2.5361160308266717
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.148935529525129
FCF margin (%): -1.5061719074402626
Revenue growth (%): 22.827487292131053
Rule of 40 score: 21.32131538469079
Financial ratios for 8093.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.159562690285082
Shares outstanding: 11935459
Market cap (USD): 121259043.9478273
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8093.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 195289367.4293405
Buffett classification: The Gruesome
Stock price: 11.993405114401078
Shares outstanding: 11935459
Book value: 198095558.5464334
P/B ratio: 0.7226148635723749
Market cap (USD): 143146795.01332438
Debt to equity: 0.17321737948839896
Current ratio: 2.0558214519623155
Quick ratio: 1.6790266512166863
Buyback yield (%): 0
Retained earnings: 73034993.2705249
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8328.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5051282051282051
Shares outstanding: 785533629
Market cap (USD): 396795192.08461535
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8328.HK — annual report dated 2022-12-31
Total revenue: 153196408.04597703
Gross profit: 23754454.022988506
Operating income: 10753160.91954023
Net income: 7892241.379310345
Capital expenditures: 64717959.77011494
Operating cash flow: -42594109.1954023
Depreciation & amortization: 5443821.839080459
Net tangible assets: 158538362.06896552
Owner earnings: -51381896.551724136
Return on net tangible assets (%): -32.409756150610775
Capex to operating income (%): 601.8505651906684
Buffett classification: The Gruesome
Stock price: 0.6636713735558408
P/E ratio: 66.05679647602093
Shares outstanding: 785533629
Book value: 165300287.3563218
P/B ratio: 3.1538734195237086
Market cap (USD): 521336182.5327343
Debt to equity: 0.3035741292840442
Current ratio: 1.342822296503749
Quick ratio: 0.8214272091225745
Effective tax rate (%): 28.483080969182495
Interest coverage ratio: 15.654047270445515
COGS to revenue (%): 84.49411815461146
SG&A to revenue (%): 9.100424198145458
Free cash flow (dilution-adjusted): -110141379.31034483
Buyback yield (%): 0
Retained earnings: 36014367.816091955
Inventory turnover: 1.7344687044563252
Receivables turnover: 2.867951476679757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.722801742792782
FCF margin (%): -71.89553640010242
Rule of 40 score: -71.89553640010242
Financial ratios for 8328.HK — annual report dated 2023-12-31
Total revenue: 195774964.83825597
Gross profit: 27467229.254571024
Operating income: 15449929.676511955
Net income: 12953586.497890295
Capital expenditures: 13120253.164556962
Operating cash flow: -733614.6272855133
Depreciation & amortization: 6231926.863572433
Net tangible assets: 154850351.61744022
Owner earnings: 6065260.196905766
Return on net tangible assets (%): 3.916852712023586
Capex to operating income (%): 84.92111899061439
Buffett classification: The Gruesome
Stock price: 0.2560819462227913
P/E ratio: 15.529365598518561
Shares outstanding: 785533629
Book value: 172332348.8045007
P/B ratio: 1.1672850856688288
Market cap (USD): 201160980.5377721
Debt to equity: 0.44836662224155566
Current ratio: 1.2347362063797147
Quick ratio: 0.9608750947787907
Effective tax rate (%): 15.985550609355617
Interest coverage ratio: 7.299906964380649
COGS to revenue (%): 85.96999913790626
SG&A to revenue (%): 11.2275496422311
Free cash flow (dilution-adjusted): -24396483.82559775
Buyback yield (%): 0
Retained earnings: 46191983.12236287
Inventory turnover: 4.815662286967545
Receivables turnover: 4.160482055911073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.703474203820986
FCF margin (%): -12.46149314635478
Revenue growth (%): 27.79344328980634
Rule of 40 score: 15.33195014345156
Financial ratios for 8328.HK — annual report dated 2024-12-31
Total revenue: 169023287.67123288
Gross profit: 27824246.575342465
Operating income: 4370136.98630137
Net income: -26995753.424657535
Capital expenditures: 5221232.876712329
Operating cash flow: 4174931.506849315
Depreciation & amortization: 9172739.726027397
Net tangible assets: 123743972.60273974
Owner earnings: -23044246.57534247
Return on net tangible assets (%): -18.622520427174535
Capex to operating income (%): 119.47526800827535
Buffett classification: The Gruesome
Stock price: 0.1056701030927835
Shares outstanding: 785533629
Book value: 132040000.00000003
P/B ratio: 0.6286535864834771
Market cap (USD): 83007419.55927835
Debt to equity: 0.501886103422375
Current ratio: 1.0841750962313133
Quick ratio: 0.9180867126189838
Interest coverage ratio: 1.8002370069409175
COGS to revenue (%): 83.53821715415724
SG&A to revenue (%): 15.46370363166298
Free cash flow (dilution-adjusted): -5851917.808219178
Buyback yield (%): 0
Retained earnings: 17990000
Inventory turnover: 7.4073358102232785
Receivables turnover: 3.6574174252506957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7128704451719883
FCF margin (%): -3.462196179500271
Revenue growth (%): -13.664503624927024
Rule of 40 score: -17.126699804427297
Financial ratios for 8328.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 123743972.60273974
Buffett classification: The Gruesome
Stock price: 0.1056701030927835
Shares outstanding: 785533629
Book value: 132040000.00000003
P/B ratio: 0.6286535864834771
Market cap (USD): 83007419.55927835
Debt to equity: 0.501886103422375
Current ratio: 1.0841750962313133
Quick ratio: 0.9180867126189838
Buyback yield (%): 0
Retained earnings: 17990000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8347.HK — annual report dated 2022-03-31
Total revenue: 45654022.98850574
Gross profit: 624776.5006385696
Operating income: -3377011.4942528736
Net income: -3986845.4661558107
Capital expenditures: 764495.5300127714
Operating cash flow: -1925415.0702426564
Depreciation & amortization: 194380.58748403576
Net tangible assets: 12180076.628352491
Owner earnings: -4556960.408684546
Return on net tangible assets (%): -37.41323267274824
Buffett classification: The Gruesome
Stock price: 0.04853128991060025
Shares outstanding: 137520190
Book value: 12180076.62835249
P/B ratio: 0.547946651986998
Market cap (USD): 6674032.20945083
Debt to equity: 0.4619586872182028
Current ratio: 1.5406647517439476
Quick ratio: 1.5310510580925025
Interest coverage ratio: -5.959432048681542
COGS to revenue (%): 98.63149738020707
SG&A to revenue (%): 3.9337456744742934
Free cash flow (dilution-adjusted): -1927203.0651340997
Buyback yield (%): 0
Retained earnings: -1719157.0881226053
Inventory turnover: 429.9743902439024
Receivables turnover: 4.292192978243119
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.590308645839855
FCF margin (%): -4.221321449851876
Rule of 40 score: -4.221321449851876
Financial ratios for 8347.HK — annual report dated 2023-03-31
Total revenue: 54769426.75159236
Gross profit: 2068917.1974522294
Operating income: -1498726.1146496816
Net income: -616178.3439490446
Capital expenditures: 1210445.8598726115
Operating cash flow: 1304968.152866242
Depreciation & amortization: 300127.3885350319
Net tangible assets: 12898598.726114651
Owner earnings: -1526496.8152866242
Return on net tangible assets (%): -11.83459418887155
Buffett classification: The Gruesome
Stock price: 0.029299363057324845
Shares outstanding: 137520190
Book value: 12898598.72611465
P/B ratio: 0.3123792018093113
Market cap (USD): 4029253.9745222935
Debt to equity: 0.4502439409801095
Current ratio: 1.5693146417445485
Quick ratio: 1.5644105334890968
Interest coverage ratio: -4.177911931818182
COGS to revenue (%): 96.22249616225518
SG&A to revenue (%): 4.274549937200539
Free cash flow (dilution-adjusted): 49936.30573248408
Buyback yield (%): 0
Retained earnings: -2330955.414012739
Inventory turnover: 1026.5483870967741
Receivables turnover: 5.670984250929908
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.478944698122781
FCF margin (%): 0.09117551286225985
Revenue growth (%): 19.966266204802128
Rule of 40 score: 20.05744171766439
Financial ratios for 8347.HK — annual report dated 2024-03-31
Total revenue: 37034482.75862069
Gross profit: 1823116.219667944
Operating income: -976117.4968071519
Net income: -1104469.987228608
Capital expenditures: 3831.417624521073
Operating cash flow: -971647.5095785441
Depreciation & amortization: 276500.6385696041
Net tangible assets: 11710983.397190293
Owner earnings: -831800.7662835249
Return on net tangible assets (%): -7.102740547673315
Buffett classification: The Gruesome
Stock price: 0.00895140664961637
Shares outstanding: 137520190
Book value: 11710983.397190295
P/B ratio: 0.10511492514948391
Market cap (USD): 1230999.1432225066
Debt to equity: 0.4055748824934294
Current ratio: 1.6165876710594786
Quick ratio: 1.598866401316437
Interest coverage ratio: -3.55985095482068
COGS to revenue (%): 95.07724670666943
SG&A to revenue (%): 4.919649631009036
Free cash flow (dilution-adjusted): -971647.5095785441
Buyback yield (%): 0
Retained earnings: -3441379.3103448274
Inventory turnover: 218.81349206349208
Receivables turnover: 3.4434931303511416
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.242919695433661
FCF margin (%): -2.623629215807987
Revenue growth (%): -32.381102094438205
Rule of 40 score: -35.00473131024619
Financial ratios for 8347.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 12045431.145431146
Buffett classification: The Gruesome
Stock price: 0.00900900900900901
Shares outstanding: 137520190
Book value: 12045431.145431146
P/B ratio: 0.10285398801192398
Market cap (USD): 1238920.6306306308
Debt to equity: 0.2655967860844294
Current ratio: 1.6912178770949722
Quick ratio: 1.6701080074487897
Buyback yield (%): 0
Retained earnings: -3223938.223938224
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8347.HK — annual report dated 2025-03-31
Total revenue: 44445758.35475578
Gross profit: 2232776.3496143958
Operating income: 151542.41645244215
Net income: -106041.13110539845
Capital expenditures: 51413.88174807198
Operating cash flow: 2799228.791773779
Depreciation & amortization: 246786.63239074548
Net tangible assets: 11654241.645244215
Owner earnings: 89331.61953727505
Capex to operating income (%): 33.92705682782019
Buffett classification: The Good
Stock price: 0.011568123393316195
Shares outstanding: 137520190
Book value: 11654241.645244215
P/B ratio: 0.13650399360317636
Market cap (USD): 1590850.526992288
Debt to equity: 0.1604940994816367
Current ratio: 2.023070855790719
Quick ratio: 1.959686253888962
Interest coverage ratio: 0.7415094339622642
COGS to revenue (%): 94.97640172591298
SG&A to revenue (%): 4.319987969507328
Free cash flow (dilution-adjusted): 2747814.910025707
Buyback yield (%): 0
Retained earnings: -3569537.275064267
Inventory turnover: 113.52125820947113
Receivables turnover: 5.601257005863868
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2883274690211333
FCF margin (%): 6.1824007773549114
Revenue growth (%): 20.011824235374092
Rule of 40 score: 26.194225012729003
Financial ratios for 8347.HK — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 11654241.645244215
Buffett classification: The Gruesome
Stock price: 0.011568123393316195
Shares outstanding: 137520190
Book value: 11654241.645244215
P/B ratio: 0.13650399360317636
Market cap (USD): 1590850.526992288
Debt to equity: 0.1604940994816367
Current ratio: 2.023070855790719
Quick ratio: 1.959686253888962
Buyback yield (%): 0
Retained earnings: -3569537.275064267
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8360.HK — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 363076.92307692306
Buffett classification: The Gruesome
Stock price: 0.06025641025641026
Shares outstanding: 360274000
Market cap (USD): 21708817.948717948
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8360.HK — annual report dated 2022-12-31
Total revenue: 17979974.32605905
Gross profit: 1965596.919127086
Operating income: -1993324.7753530166
Net income: -2300256.7394094993
Capital expenditures: 110141.20667522465
Operating cash flow: -2280744.544287548
Depreciation & amortization: 366623.87676508346
Net tangible assets: 1149037.2272143774
Owner earnings: -2043774.0693196405
Return on net tangible assets (%): -177.86839459278295
Buffett classification: The Gruesome
Stock price: 0.11938382541720155
Shares outstanding: 360274000
Book value: -1999229.7817715025
Market cap (USD): 43010888.31835687
Debt to equity: -1.0314626942339795
Current ratio: 0.8649709450504639
Quick ratio: 0.8649709450504639
Interest coverage ratio: -8.660345789180145
COGS to revenue (%): 89.06785469499657
SG&A to revenue (%): 4.894905186200594
Free cash flow (dilution-adjusted): -2426187.4197689346
Buyback yield (%): 0
Retained earnings: -21526957.637997434
Receivables turnover: 14.641856575371108
Capitalized R&D asset: 0
FCF margin (%): -13.493831391363948
Rule of 40 score: -13.493831391363948
Financial ratios for 8360.HK — annual report dated 2023-12-31
Total revenue: 8170550.57618438
Gross profit: 1954161.3316261205
Operating income: -2411907.81049936
Net income: -2030345.7106274008
Capital expenditures: 71190.78104993598
Operating cash flow: 108322.66325224072
Depreciation & amortization: 310755.44174135727
Net tangible assets: 768.245838668374
Owner earnings: -1790781.0499359795
Return on net tangible assets (%): -233100
Buffett classification: The Gruesome
Stock price: 0.1088348271446863
Shares outstanding: 360274000
Book value: -37900.1280409731
Market cap (USD): 39210358.51472471
Debt to equity: -110.21959459459464
Current ratio: 1.8838931297709924
Quick ratio: 1.8838931297709924
Interest coverage ratio: -9.993103448275862
COGS to revenue (%): 76.08286842600137
SG&A to revenue (%): 8.780480160471384
Free cash flow (dilution-adjusted): -447503.20102432783
Buyback yield (%): 0
Retained earnings: -23502176.696542896
Receivables turnover: 23.77496274217586
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -70.84242196314405
FCF margin (%): -5.477026264652417
Revenue growth (%): -54.557495867263306
Rule of 40 score: -60.03452213191572
Financial ratios for 8360.HK — annual report dated 2024-12-31
Total revenue: 8462242.268041238
Gross profit: 2459278.350515464
Operating income: -1932345.3608247424
Net income: -1393814.4329896907
Capital expenditures: 42268.0412371134
Operating cash flow: -2285438.144329897
Depreciation & amortization: 116108.24742268042
Net tangible assets: -2390850.5154639175
Owner earnings: -1319974.2268041235
Buffett classification: The Gruesome
Stock price: 0.07731958762886598
Shares outstanding: 360274000
Book value: -1381443.2989690732
Market cap (USD): 27856237.11340206
Debt to equity: -6.94673507462686
Current ratio: 1.539465112292131
Quick ratio: 1.539465112292131
Interest coverage ratio: -4.78156887755102
COGS to revenue (%): 70.93821858772289
SG&A to revenue (%): 15.644083024959263
Free cash flow (dilution-adjusted): -2327706.18556701
Buyback yield (%): 0
Retained earnings: -25104896.907216497
Receivables turnover: 9.38770550393138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.84148002963884
FCF margin (%): -27.50696696971081
Revenue growth (%): 3.5700371613521957
Rule of 40 score: -23.936929808358613
Financial ratios for 8360.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2390850.5154639175
Buffett classification: The Gruesome
Stock price: 0.07731958762886598
Shares outstanding: 360274000
Book value: -1381443.2989690732
Market cap (USD): 27856237.11340206
Debt to equity: -6.94673507462686
Current ratio: 1.539465112292131
Quick ratio: 1.539465112292131
Buyback yield (%): 0
Retained earnings: -25104896.907216497
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8360.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -4235923.566878981
Buffett classification: The Gruesome
Stock price: 0.05477707006369427
Shares outstanding: 360274000
Book value: -3233757.961783439
Market cap (USD): 19734754.14012739
Debt to equity: -4.072483750246209
Current ratio: 1.45032080659945
Quick ratio: 1.45032080659945
Buyback yield (%): 0
Retained earnings: -26805859.872611467
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9028.T — annual report dated 2021-06-30
Total revenue: 833824859.7792654
Gross profit: 121241179.66347022
Operating income: 48235932.6940474
Net income: 32802605.391713407
Capital expenditures: 25918219.648995835
Operating cash flow: 77745612.44798262
Depreciation & amortization: 41442011.94137868
Net tangible assets: 234847114.16681743
Owner earnings: 48326397.68409626
Return on net tangible assets (%): 20.57781201848999
Capex to operating income (%): 53.73218304576144
Buffett classification: The Good
Stock price: 9.517912068029672
P/E ratio: 4.875587419420849
Shares outstanding: 16803262
Book value: 255997828.84023884
P/B ratio: 0.6247395569587956
Market cap (USD): 159931970.1720644
Debt to equity: 0.37543289278394226
Current ratio: 1.353667588906134
Quick ratio: 1.2911127606451176
Effective tax rate (%): 32.737762888516656
Interest coverage ratio: 140.31578947368422
COGS to revenue (%): 85.45854986926473
SG&A to revenue (%): 9.492139610072584
Free cash flow (dilution-adjusted): 50090464.99004885
Buyback yield (%): 0
Retained earnings: 197295096.79753935
Inventory turnover: 84.97087378640776
Receivables turnover: 7.137292860461515
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.763539705393727
FCF margin (%): 6.007312495253387
Rule of 40 score: 6.007312495253387
Financial ratios for 9028.T — annual report dated 2022-06-30
Total revenue: 783695731.7519584
Gross profit: 96105132.14730214
Operating income: 28640456.84164287
Net income: 18559191.741708763
Capital expenditures: 18961856.651292186
Operating cash flow: 28947946.408961125
Depreciation & amortization: 34277765.57581082
Net tangible assets: 196149059.2283476
Owner earnings: 33875100.6662274
Return on net tangible assets (%): 17.270080621080922
Capex to operating income (%): 66.20654396728017
Buffett classification: The Good
Stock price: 6.493960026356248
P/E ratio: 5.879550858627218
Shares outstanding: 16803262
Book value: 224130609.8543085
P/B ratio: 0.4868576934284968
Market cap (USD): 109119711.74039094
Debt to equity: 0.3436336316717842
Current ratio: 1.320648381729376
Quick ratio: 1.1809350008051098
Effective tax rate (%): 36.1033696478338
Interest coverage ratio: 100.30769230769229
COGS to revenue (%): 87.73693306553318
SG&A to revenue (%): 8.738381054696625
Free cash flow (dilution-adjusted): 9253971.740244526
Buyback yield (%): 0
Retained earnings: 171608463.28428143
Inventory turnover: 36.080676142912026
Receivables turnover: 6.742142722176734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.700804201542754
FCF margin (%): 1.1808118081180812
Revenue growth (%): -6.011949324775168
Rule of 40 score: -4.831137516657087
Financial ratios for 9028.T — annual report dated 2023-06-30
Total revenue: 917675093.2449234
Gross profit: 104986876.64041995
Operating income: 35053184.141456
Net income: 23849979.278905924
Capital expenditures: 13081917.39190496
Operating cash flow: 60629921.25984252
Depreciation & amortization: 34569691.94640144
Net tangible assets: 206568586.82138416
Owner earnings: 45337753.8334024
Return on net tangible assets (%): 21.948038920654028
Capex to operating income (%): 37.32019704433498
Buffett classification: The Good
Stock price: 8.150849564857024
P/E ratio: 5.7425987318158125
Shares outstanding: 16803262
Book value: 233706313.02666116
P/B ratio: 0.5860383443953185
Market cap (USD): 136960860.76087856
Debt to equity: 0.21559877054025295
Current ratio: 1.4303296703296704
Quick ratio: 1.1704395604395605
Effective tax rate (%): 32.00787401574803
Interest coverage ratio: 115.34090909090908
COGS to revenue (%): 88.55947192930958
SG&A to revenue (%): 7.775795756467286
Free cash flow (dilution-adjusted): 45489708.523276694
Buyback yield (%): 0
Retained earnings: 182525210.66445643
Inventory turnover: 24.875475687103595
Receivables turnover: 8.95108805497541
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.230616820480732
FCF margin (%): 4.957060386418888
Revenue growth (%): 17.095839120299022
Rule of 40 score: 22.05289950671791
Financial ratios for 9028.T — annual report dated 2024-06-30
Total revenue: 875916360.694505
Gross profit: 109950837.01537122
Operating income: 38726740.929740496
Net income: 26162175.61764889
Capital expenditures: 13591387.142946046
Operating cash flow: 69904785.61204804
Depreciation & amortization: 31955940.00871243
Net tangible assets: 198400647.20891157
Owner earnings: 44526728.483415276
Return on net tangible assets (%): 22.442834290016002
Capex to operating income (%): 35.09561304836895
Buffett classification: The Good
Stock price: 10.57925197585413
P/E ratio: 6.794769109124643
Shares outstanding: 16803262
Book value: 235689837.5754558
P/B ratio: 0.7542367738167034
Market cap (USD): 177765942.7142946
Debt to equity: 0.3762046840757268
Current ratio: 1.3664940981569684
Quick ratio: 1.2431145164630357
Effective tax rate (%): 32.48755419945399
Interest coverage ratio: 135.2826086956522
COGS to revenue (%): 87.44733607576501
SG&A to revenue (%): 8.026230719497553
Free cash flow (dilution-adjusted): 52567054.5771361
Buyback yield (%): 0
Retained earnings: 187354533.5739623
Inventory turnover: 41.3168848606915
Receivables turnover: 8.123686944476509
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.357516957156351
FCF margin (%): 6.001378320580315
Revenue growth (%): -4.550492092223882
Rule of 40 score: 1.450886228356433
Financial ratios for 9028.T — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 217956557.74253136
Buffett classification: The Gruesome
Stock price: 15.412808006587698
Shares outstanding: 16803262
Book value: 258494171.6032868
P/B ratio: 1.00190054376877
Market cap (USD): 258985451.0903908
Debt to equity: 0.36593479707252163
Current ratio: 1.4529526789206102
Quick ratio: 1.1567070786077436
Buyback yield (%): 0
Retained earnings: 209127969.93439072
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9028.T — annual report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.352961527816216
Shares outstanding: 16803262
Market cap (USD): 341996145.0278162
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9028.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.150538358008074
Shares outstanding: 16803262
Market cap (USD): 338594775.47065943
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9254.T — annual report dated 2022-03-31
Total revenue: 11376159.645959679
Gross profit: 6628773.9714800855
Operating income: 1641780.0360596625
Net income: 789149.3197836421
Capital expenditures: 1786.592361907884
Operating cash flow: 1861793.1486641534
Depreciation & amortization: 46934.92870021308
Net tangible assets: 3643001.147352893
Owner earnings: 834297.6561219472
Return on net tangible assets (%): 22.901383292952605
Capex to operating income (%): 0.10882044626366494
Buffett classification: The Great
Stock price: 14.677921652188166
P/E ratio: 29.799935872138906
Shares outstanding: 1602175
Book value: 3806294.0501557114
P/B ratio: 6.178345344110378
Market cap (USD): 23516599.123094574
Debt to equity: 0.904111152259476
Current ratio: 1.8505991668782165
Quick ratio: 1.8505991668782165
Effective tax rate (%): 48.35784234857505
Interest coverage ratio: 47.99472927647341
COGS to revenue (%): 41.73100433032038
Free cash flow (dilution-adjusted): 1860006.5563022457
Buyback yield (%): 0
Retained earnings: -496295.6892312736
Receivables turnover: 3.7125109988419456
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.64046150565827
FCF margin (%): 16.350039153703683
Rule of 40 score: 16.350039153703683
Financial ratios for 9254.T — annual report dated 2023-03-31
Total revenue: 12415172.672672674
Gross profit: 6612372.372372373
Operating income: 602815.3153153154
Net income: 367680.18018018024
Capital expenditures: 418716.2162162163
Operating cash flow: -1322837.8378378379
Depreciation & amortization: 77304.80480480481
Net tangible assets: 4004151.651651652
Owner earnings: 26268.768768768758
Return on net tangible assets (%): 0.6560383085873706
Capex to operating income (%): 69.46011582290305
Buffett classification: The Good
Stock price: 13.753753753753754
P/E ratio: 59.93230423685553
Shares outstanding: 1602175
Book value: 4149834.8348348346
P/B ratio: 5.310071676936381
Market cap (USD): 22035920.42042042
Debt to equity: 0.9990411717243352
Current ratio: 2.1833017886033637
Quick ratio: 2.181678752133992
Effective tax rate (%): 38.7072148175959
Interest coverage ratio: 18.33219178082192
COGS to revenue (%): 46.73958593482135
Free cash flow (dilution-adjusted): -1741554.0540540542
Buyback yield (%): 0
Retained earnings: -121644.14414414416
Inventory turnover: 817.9185185185186
Receivables turnover: 3.7047514074552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.68345316800089
FCF margin (%): -14.027626517732045
Revenue growth (%): 9.1332493481841
Rule of 40 score: -4.894377169547946
Financial ratios for 9254.T — annual report dated 2024-10-31
Total revenue: 14111403.394255877
Gross profit: 7363955.613577024
Operating income: 895659.268929504
Net income: 503603.13315926894
Capital expenditures: 33994.77806788512
Operating cash flow: 1706325.0652741515
Depreciation & amortization: 193498.6945169713
Net tangible assets: 1284295.039164491
Owner earnings: 663107.0496083552
Return on net tangible assets (%): 51.63198715146833
Capex to operating income (%): 3.79550340706191
Buffett classification: The Great
Stock price: 9.823759791122717
P/E ratio: 31.253543330049776
Shares outstanding: 1602175
Book value: 1998289.817232376
P/B ratio: 7.876426235880552
Market cap (USD): 15739382.343342038
Debt to equity: 3.157804650190437
Current ratio: 1.65362468075305
Quick ratio: 1.6103606502588974
Effective tax rate (%): 47.829027001075175
Interest coverage ratio: 18.876736827624157
COGS to revenue (%): 47.81552241650388
Free cash flow (dilution-adjusted): 1672330.2872062665
Buyback yield (%): 14.840581897935982
Retained earnings: 1049497.3890339427
Inventory turnover: 26.97708648676862
Receivables turnover: 5.9679691921213545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.315928408015335
FCF margin (%): 11.850914047903965
Revenue growth (%): 13.662562465335787
Rule of 40 score: 25.513476513239752
Financial ratios for 9254.T — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 1103689.3886156008
Buffett classification: The Gruesome
Stock price: 9.26212227687983
Shares outstanding: 1602175
Book value: 2695186.2262825016
P/B ratio: 5.505942637376964
Market cap (USD): 14839540.758959943
Debt to equity: 2.7386063489994132
Current ratio: 1.4470203345189085
Quick ratio: 1.4310772836152097
Buyback yield (%): 0
Retained earnings: 1513485.5938158818
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9254.T — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 1660090.9681611436
Buffett classification: The Gruesome
Stock price: 8.505523066926575
Shares outstanding: 1602175
Book value: 3017771.280051982
P/B ratio: 4.515695576345451
Market cap (USD): 13627336.419753084
Debt to equity: 2.23129824410305
Current ratio: 1.49383736940229
Quick ratio: 1.4558231495741003
Buyback yield (%): 0
Retained earnings: 1910058.4795321636
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9254.T — annual report dated 2025-10-31
Total revenue: 17092748.538011696
Gross profit: 8253391.812865497
Operating income: 1041923.3268356075
Net income: 873274.8538011695
Capital expenditures: 54814.81481481481
Operating cash flow: -12287.199480181936
Depreciation & amortization: 373053.9311241066
Net tangible assets: 1660090.9681611436
Owner earnings: 1191513.9701104613
Return on net tangible assets (%): 71.77401678356713
Capex to operating income (%): 5.26092596288166
Buffett classification: The Great
Stock price: 8.505523066926575
P/E ratio: 15.604865249968375
Shares outstanding: 1602175
Book value: 3017771.280051982
P/B ratio: 4.515695576345451
Market cap (USD): 13627336.419753084
Debt to equity: 2.23129824410305
Current ratio: 1.49383736940229
Quick ratio: 1.4558231495741003
Effective tax rate (%): 8.343960772813759
Interest coverage ratio: 10.543230981655599
COGS to revenue (%): 51.714074570797095
Free cash flow (dilution-adjusted): -114470.43534762833
Buyback yield (%): 0
Retained earnings: 1910058.4795321636
Inventory turnover: 36.0441153092046
Receivables turnover: 5.936535805522707
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.32523715884781
FCF margin (%): -0.669701745702649
Revenue growth (%): 21.127205143674033
Rule of 40 score: 20.457503397971383
Financial ratios for 9366.T — annual report dated 2022-03-31
Total revenue: 151823684.641862
Gross profit: 31483224.061629243
Operating income: 8694705.785936732
Net income: 6327421.734141944
Capital expenditures: 6933379.773807573
Operating cash flow: 10097754.466480905
Depreciation & amortization: 6042312.735617112
Net tangible assets: 75600393.37813473
Owner earnings: 5436354.695951483
Return on net tangible assets (%): 7.190907947740646
Capex to operating income (%): 79.74254614827774
Buffett classification: The Gruesome
Stock price: 5.652597934764793
P/E ratio: 5.036953631785636
Shares outstanding: 5638280
Book value: 77432224.22553681
P/B ratio: 0.41159775794112785
Market cap (USD): 31870929.883625634
Debt to equity: 0.7381208008230068
Current ratio: 1.1258075328724144
Quick ratio: 1.080594252213944
Effective tax rate (%): 30.525240709079455
Interest coverage ratio: 13.184143158941222
COGS to revenue (%): 79.26329325277996
SG&A to revenue (%): 15.009857209992312
Free cash flow (dilution-adjusted): 1907015.243402721
Buyback yield (%): 0.0008999995428105182
Retained earnings: 35347877.39714801
Inventory turnover: 54.51176068782204
Receivables turnover: 5.450479569740621
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.3039593726347425
FCF margin (%): 1.2560722972184433
Rule of 40 score: 1.2560722972184433
Financial ratios for 9366.T — annual report dated 2023-03-31
Total revenue: 152665578.0780781
Gross profit: 31100457.95795796
Operating income: 7650518.018018018
Net income: 7444624.624624625
Capital expenditures: 5196298.7987987995
Operating cash flow: 10626351.351351352
Depreciation & amortization: 5764662.162162162
Net tangible assets: 74074647.14714715
Owner earnings: 8012987.987987988
Return on net tangible assets (%): 10.817450094727308
Capex to operating income (%): 67.92087524741206
Buffett classification: The Good
Stock price: 5.0026276276276285
P/E ratio: 3.788802891015143
Shares outstanding: 5638280
Book value: 76990060.06006005
P/B ratio: 0.3663617781087143
Market cap (USD): 28206215.300300304
Debt to equity: 0.6501467175864909
Current ratio: 1.1091513224464185
Quick ratio: 1.0454463195223669
Effective tax rate (%): 28.251570452200514
Interest coverage ratio: 12.504435854960427
COGS to revenue (%): 79.62837081089774
SG&A to revenue (%): 15.360332194823176
Free cash flow (dilution-adjusted): 177297.2972972973
Buyback yield (%): 3.397197073478053
Retained earnings: 38049459.45945946
Inventory turnover: 40.960730249394786
Receivables turnover: 5.838666886794485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.809220430527843
FCF margin (%): 0.11613442894548355
Revenue growth (%): 0.5545204874997169
Rule of 40 score: 0.6706549164452005
Financial ratios for 9366.T — annual report dated 2024-03-31
Total revenue: 128091409.13893291
Gross profit: 28880355.25620708
Operating income: 5715207.34284205
Net income: 3851835.710512414
Capital expenditures: 5648996.302165874
Operating cash flow: 7284891.706286318
Depreciation & amortization: 5082699.41891178
Net tangible assets: 68833597.46434231
Owner earnings: 3285538.8272583196
Return on net tangible assets (%): 4.773161578486899
Capex to operating income (%): 98.84149363786248
Buffett classification: The Gruesome
Stock price: 5.5986529318541995
P/E ratio: 8.195254217739087
Shares outstanding: 5638280
Book value: 71164837.55942948
P/B ratio: 0.44357261163216466
Market cap (USD): 31566772.852614895
Debt to equity: 0.6089387942307479
Current ratio: 1.1221023592581956
Quick ratio: 1.0442374400612657
Effective tax rate (%): 24.10903513120045
Interest coverage ratio: 11.972265641210077
COGS to revenue (%): 77.45331864671928
SG&A to revenue (%): 18.08485679803804
Free cash flow (dilution-adjusted): 1239850.765979926
Buyback yield (%): 0.0008576558822437209
Retained earnings: 35429945.85314316
Inventory turnover: 33.58417994988477
Receivables turnover: 5.48488826733502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.544163101760651
FCF margin (%): 0.9679421706065672
Revenue growth (%): -16.09673198668082
Rule of 40 score: -15.128789816074251
Financial ratios for 9366.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 77685439.13713405
Buffett classification: The Gruesome
Stock price: 5.068637064014568
Shares outstanding: 5638280
Book value: 80016325.8159406
P/B ratio: 0.3571570513126305
Market cap (USD): 28578394.98529206
Debt to equity: 0.6270968655629616
Current ratio: 1.208533050757135
Quick ratio: 1.1393985972433618
Buyback yield (%): 0
Retained earnings: 37765114.16164729
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9366.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 76801837.98957358
Buffett classification: The Gruesome
Stock price: 5.225638283651918
Shares outstanding: 5638280
Book value: 78846277.23566367
P/B ratio: 0.3736842480702689
Market cap (USD): 29463611.821948934
Debt to equity: 0.6762934242492571
Current ratio: 1.268476888332573
Quick ratio: 1.208546699932417
Buyback yield (%): 0
Retained earnings: 37785022.055874884
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9366.T — annual report dated 2025-03-31
Total revenue: 134487608.6084748
Gross profit: 29410359.57759658
Operating income: 6916735.73051731
Net income: 3164015.5059484025
Capital expenditures: 6685543.376553937
Operating cash flow: 11116214.409838257
Depreciation & amortization: 5567363.988771554
Net tangible assets: 76801837.98957358
Owner earnings: 2045836.1181660192
Return on net tangible assets (%): 2.663785362068752
Capex to operating income (%): 96.65749331807878
Buffett classification: The Gruesome
Stock price: 5.225638283651918
P/E ratio: 9.312094636248416
Shares outstanding: 5638280
Book value: 78846277.23566367
P/B ratio: 0.3736842480702689
Market cap (USD): 29463611.821948934
Debt to equity: 0.6762934242492571
Current ratio: 1.268476888332573
Quick ratio: 1.208546699932417
Effective tax rate (%): 31.29108338957467
Interest coverage ratio: 13.058118407106445
COGS to revenue (%): 78.13154692696106
SG&A to revenue (%): 16.725424802937436
Free cash flow (dilution-adjusted): 4089693.8911910173
Buyback yield (%): 0.0003402637034010648
Retained earnings: 37785022.055874884
Inventory turnover: 39.07710700828188
Receivables turnover: 5.946289633610276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7618935284442
FCF margin (%): 3.0409447632436404
Revenue growth (%): 4.993464833074255
Rule of 40 score: 8.034409596317897
Financial ratios for 9366.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.363479103238306
Shares outstanding: 5638280
Market cap (USD): 30240796.958206475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9366.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 75162819.6500673
Buffett classification: The Gruesome
Stock price: 5.6498654104979815
Shares outstanding: 5638280
Book value: 77030471.06325705
P/B ratio: 0.413544441660534
Market cap (USD): 31855523.146702558
Debt to equity: 0.7326085672691796
Current ratio: 1.2395953919038099
Quick ratio: 1.1675640937753895
Buyback yield (%): 0
Retained earnings: 38427617.76581427
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9432.T — annual report dated 2022-03-31
Total revenue: 99626675954.76152
Gross profit: 78596295689.23128
Operating income: 14806138337.97738
Net income: 10293345353.220783
Capital expenditures: 14407842976.56122
Operating cash flow: 24670193410.916245
Depreciation & amortization: 12794484510.735945
Net tangible assets: 41940853958.367485
Owner earnings: 8679986887.395506
Return on net tangible assets (%): 20.69578005257518
Capex to operating income (%): 97.30993083865397
Buffett classification: The Gruesome
Stock price: 1.0234387805277823
P/E ratio: 8.095725171694133
Shares outstanding: 81423624610
Book value: 73906998852.64711
P/B ratio: 1.1275264368825826
Market cap (USD): 83332095077.01031
Debt to equity: 0.9103320953829462
Current ratio: 0.913392192775458
Quick ratio: 0.8481444608005031
Effective tax rate (%): 30.04864872391083
Interest coverage ratio: 32.11813333333333
COGS to revenue (%): 21.10918593236988
Free cash flow (dilution-adjusted): 10262350434.355024
Buyback yield (%): 2.494890374502634
Retained earnings: 59776389116.53828
Inventory turnover: 6.283951494017563
Receivables turnover: 3.372145702627963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.262928007574814
FCF margin (%): 10.300805819331915
Rule of 40 score: 10.300805819331915
Financial ratios for 9432.T — annual report dated 2023-03-31
Total revenue: 98620075075.07509
Gross profit: 77833956456.45647
Operating income: 13850998498.498499
Net income: 9705375375.375376
Capital expenditures: 13218190690.690691
Operating cash flow: 16974572072.072073
Depreciation & amortization: 11881569069.06907
Net tangible assets: 38701433933.93394
Owner earnings: 8368753753.753756
Return on net tangible assets (%): 21.623885481968976
Capex to operating income (%): 95.43131993064323
Buffett classification: The Gruesome
Stock price: 1.0804804804804804
P/E ratio: 9.064733061669177
Shares outstanding: 81423624610
Book value: 70199902402.40242
P/B ratio: 1.2532301902183882
Market cap (USD): 87976637041.07507
Debt to equity: 0.9786010071837962
Current ratio: 0.9729359095179434
Quick ratio: 0.8972911640462421
Effective tax rate (%): 28.878751418704844
Interest coverage ratio: 23.22916246978243
COGS to revenue (%): 21.076964910840996
Free cash flow (dilution-adjusted): 3071576576.5765767
Buyback yield (%): 0
Retained earnings: 61187064564.56457
Inventory turnover: 5.351107151209198
Receivables turnover: 3.1378445552536505
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.9895310296545
FCF margin (%): 3.1145550986838346
Revenue growth (%): -1.0103728444613662
Rule of 40 score: 2.1041822542224686
Financial ratios for 9432.T — annual report dated 2024-03-31
Total revenue: 88315960116.21765
Gross profit: 68932276809.29741
Operating income: 12793066561.014263
Net income: 8882190966.719494
Capital expenditures: 12043007131.537243
Operating cash flow: 15677225303.75066
Depreciation & amortization: 10754001584.786055
Net tangible assets: 37206722134.17855
Owner earnings: 7593185419.968304
Return on net tangible assets (%): 20.408100967843954
Capex to operating income (%): 94.13698485894884
Buffett classification: The Gruesome
Stock price: 1.109350237717908
P/E ratio: 10.169486071105975
Shares outstanding: 81423624610
Book value: 71929866613.84045
P/B ratio: 1.2557692870735393
Market cap (USD): 90327317316.95721
Debt to equity: 0.9835631111517895
Current ratio: 0.9410378779614149
Quick ratio: 0.8817809215721408
Effective tax rate (%): 32.08037336836902
Interest coverage ratio: 14.847545694907462
COGS to revenue (%): 21.94810913159145
Free cash flow (dilution-adjusted): 1915973322.768093
Buyback yield (%): 0
Retained earnings: 59945087163.23296
Inventory turnover: 5.600258315113914
Receivables turnover: 2.7765632243300793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.332922515212747
FCF margin (%): 2.169453086675167
Revenue growth (%): -10.448293566004054
Rule of 40 score: -8.278840479328887
Financial ratios for 9432.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 40944782182.37849
Buffett classification: The Gruesome
Stock price: 0.9769575570808237
Shares outstanding: 81423624610
Book value: 77429555960.21852
P/B ratio: 1.0273522093878624
Market cap (USD): 79547425387.65163
Debt to equity: 0.9883981499706207
Current ratio: 0.9927286710401781
Quick ratio: 0.920381244649453
Buyback yield (%): 0
Retained earnings: 66159280011.20605
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9432.T — annual report dated 2025-03-31
Total revenue: 91596892126.72102
Gross profit: 70887073920.59885
Operating income: 11159196631.466381
Net income: 7234560887.581874
Capital expenditures: 13665846811.92354
Operating cash flow: 15800233925.945728
Depreciation & amortization: 11509390455.821413
Net tangible assets: 40229922470.25799
Owner earnings: 5078104531.479746
Return on net tangible assets (%): 12.622705239449546
Capex to operating income (%): 122.46264012759644
Buffett classification: The Gruesome
Stock price: 0.9351690950407698
P/E ratio: 10.52515260078545
Shares outstanding: 81423624610
Book value: 75823011629.4613
P/B ratio: 1.0042446970266041
Market cap (USD): 76144857341.47305
Debt to equity: 0.9847129556083715
Current ratio: 0.9441749218269103
Quick ratio: 0.8813932536462822
Effective tax rate (%): 30.82138639071104
Interest coverage ratio: 9.849564047807261
COGS to revenue (%): 22.60973896087095
Free cash flow (dilution-adjusted): 1548850421.0667024
Buyback yield (%): 0
Retained earnings: 65007151450.34086
Inventory turnover: 5.567259457827862
Receivables turnover: 2.8079032218078748
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.876688546894356
FCF margin (%): 1.690942110703847
Revenue growth (%): 3.714993310592892
Rule of 40 score: 5.405935421296739
Financial ratios for 9432.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 40229922470.25799
Buffett classification: The Gruesome
Stock price: 0.9351690950407698
Shares outstanding: 81423624610
Book value: 75823011629.4613
P/B ratio: 1.0042446970266041
Market cap (USD): 76144857341.47305
Debt to equity: 0.9847129556083715
Current ratio: 0.9441749218269103
Quick ratio: 0.8813932536462822
Buyback yield (%): 0
Retained earnings: 65007151450.34086
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9432.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0303764184887905
Shares outstanding: 81423624610
Market cap (USD): 83896982706.02754
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9432.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 33139811574.697174
Buffett classification: The Gruesome
Stock price: 1.0236877523553163
Shares outstanding: 81423624610
Book value: 64200323014.80484
P/B ratio: 1.2983169453277135
Market cap (USD): 83352367265.63391
Debt to equity: 1.6341889367147415
Current ratio: 0.9778630810051995
Quick ratio: 0.9202033595205766
Buyback yield (%): 0
Retained earnings: 57282153432.0323
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AARTIPHARM.NS — annual report dated 2023-03-31
Total revenue: 235810535.9317905
Gross profit: 83073885.50548112
Operating income: 34044920.828258224
Net income: 23568026.796589527
Capital expenditures: 12439500.6090134
Operating cash flow: 30464725.94397077
Depreciation & amortization: 7617868.453105968
Net tangible assets: 184757161.99756396
Owner earnings: 18746394.640682094
Return on net tangible assets (%): 10.146504978751118
Capex to operating income (%): 36.53849181134905
Buffett classification: The Good
Stock price: 3.314250913520098
P/E ratio: 12.75183771925155
Shares outstanding: 90679813
Book value: 189827844.09257007
P/B ratio: 1.583201107876064
Market cap (USD): 300535653.0730817
Debt to equity: 0.1381550537553547
Current ratio: 1.9363313184268212
Quick ratio: 0.9339711040229202
Effective tax rate (%): 25.800537475246838
Interest coverage ratio: 13.277255518556695
COGS to revenue (%): 64.7709186626374
R&D to revenue (%): 0.7210985305044487
SG&A to revenue (%): 4.555412965207467
Free cash flow (dilution-adjusted): 15890194.884287456
Buyback yield (%): 0
Retained earnings: 108330694.27527407
Inventory turnover: 2.08286130014401
Receivables turnover: 4.301240069512854
Capitalized R&D asset: 1700426.3093788065
ROCI (R&D-adjusted, %): 17.426246751688183
FCF margin (%): 6.738543221361315
Rule of 40 score: 6.738543221361315
Financial ratios for AARTIPHARM.NS — annual report dated 2024-03-31
Total revenue: 217712579.44597673
Gross profit: 84235855.61817963
Operating income: 37511895.91078067
Net income: 26010564.81592517
Capital expenditures: 18659815.325578608
Operating cash flow: 25944909.461566135
Depreciation & amortization: 8782264.060438901
Net tangible assets: 201461146.42043412
Owner earnings: 16133013.55078546
Return on net tangible assets (%): 8.008002454784549
Capex to operating income (%): 49.743727616326375
Buffett classification: The Good
Stock price: 5.166626679462572
P/E ratio: 18.01224788658295
Shares outstanding: 90679813
Book value: 210701427.02961984
P/B ratio: 2.2235670054034107
Market cap (USD): 468508741.134477
Debt to equity: 0.16234925208270826
Current ratio: 1.9378774810837327
Quick ratio: 1.0120877473451124
Effective tax rate (%): 27.81767900642945
Interest coverage ratio: 18.171196709788727
COGS to revenue (%): 61.30868697043667
R&D to revenue (%): 0.4610342068973418
SG&A to revenue (%): 4.426239043545566
Free cash flow (dilution-adjusted): 2106907.303033937
Buyback yield (%): 0
Retained earnings: 130203477.63520806
Inventory turnover: 1.7314272834308897
Receivables turnover: 3.4957635049111917
Capitalized R&D asset: 2143015.0912483046
ROCI (R&D-adjusted, %): 16.460293532024036
Rosenberg metric: 0.6833404695573059
FCF margin (%): 0.9677471593030964
Revenue growth (%): -7.6747870549128905
Rule of 40 score: -6.707039895609794
Financial ratios for AARTIPHARM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 210820138.55709508
Buffett classification: The Gruesome
Stock price: 7.542881032011467
Shares outstanding: 90679813
Book value: 221778153.36837077
P/B ratio: 3.084104683331693
Market cap (USD): 683987041.4640468
Debt to equity: 0.20814576534069337
Current ratio: 2.0141903148749067
Quick ratio: 0.961067601402396
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0